Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 107 clinical trials
Jaktinib Hydrochloride Cream For Atopic Dermatitis

This study includes a dose escalation part and a dose extension part.

  • 0 views
  • 09 Dec, 2021
  • 1 location
Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

This is a randomized, double-blind, placebo-controlled, multicenter Phase 3 study that will enroll approximately 330 subjects aged 12 to 75 years old with moderate to severe atopic dermatitis.

  • 278 views
  • 15 May, 2021
  • 44 locations
The Role of IL-22/IL-22BP Axis in Atopic Dermatitis

Interleukin 22 (IL-22) is known to be regulated by IL-22 binding protein (IL-22BP), a soluble, inhibitory receptor. The potential role of IL-22BP in atopic dermatitis (AD) is mostly unknown and deserves further investigation. The main objective of this study is to better understand the potential protective role of IL-22BP through …

  • 0 views
  • 27 Jan, 2021
  • 1 location
Clinical Study of Jaktinib in the Treatment of Patients With Moderate and Severe Atopic Dermatitis

The purpose of this study is to evaluate the efficacy and safety of Jaktinib in participants with moderate to severe atopic dermatitis.

  • 0 views
  • 26 Jan, 2021
  • 1 location
Apremilast 30 mg BID Combined With Dupilumab

Open label phase 2 investigational study of efficacy and safety of apremilast 30 mg BID in chronic atopic dermatitis when added to the FDA approved treatment dupilumab for atopic dermatitis that is not providing adequate clinical responses.

vasectomy
dupilumab
atopy
treatment regimen
  • 0 views
  • 02 Jun, 2021
  • 1 location
A Phase I/IIa Study to Investigate the GM-XANTHO in Healthy Volunteers and Atopic Dermatitis Patients

A Phase I/IIa Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GM-XANTHO in Healthy Volunteers and to Investigate its Efficacy and Safety Profile in Atopic Dermatitis Patients

platelet count
topical corticosteroid
topical agents
atopy
corticosteroids
  • 49 views
  • 27 Apr, 2022
  • 1 location
A First-in-Human PoC Study With BEN2293 in Patients With Mild to Moderate Atopic Dermatitis

A randomised, adaptive design, double-blind, placebo-controlled, first-in-human, two-part study to investigate the safety, tolerability, PK and preliminary efficacy of multiple topical doses of BEN2293 in patients with mild to moderate AD.

  • 0 views
  • 26 Apr, 2022
  • 1 location
A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis (BREEZE-AD-PEDS)

The reason for this study is to see if the study drug called baricitinib works and is safe in children and teenage participants with atopic dermatitis.

topical corticosteroid
topical agents
atopy
ly3009104
corticosteroids
  • 123 views
  • 29 Apr, 2022
  • 10 locations
Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic Dermatitis

This is the first time PF-07242813 will be given to humans. The purpose of the study is to evaluate the safety, tolerability, and pharmacokinetics of escalating single and repeat doses of PF-07242813 in healthy participants and in participants with moderate to severe atopic dermatitis. An additional goal is to assess …

Accepts healthy volunteers
  • 0 views
  • 30 Apr, 2022
  • 2 locations
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Upadacitinib in Pediatric Participants With Severe Atopic Dermatitis

The objective of this study is to evaluate the safety, pharmacokinetics and tolerability of multiple doses of upadacitinib in pediatric participants with severe atopic dermatitis and to evaluate palatability of upadacitinib oral solution in pediatric participants.

topical corticosteroid
topical agents
atopy
calcineurin inhibitor
corticosteroids
  • 239 views
  • 05 May, 2022
  • 13 locations